These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1567166)

  • 1. Levamisole in the treatment of cancer: anything new? (Review).
    De Brabander M; De Crée J; Vandebroek J; Verhaegen H; Janssen PA
    Anticancer Res; 1992; 12(1):177-87. PubMed ID: 1567166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levamisole in the adjuvant treatment of colon cancer.
    Mutch RS; Hutson PR
    Clin Pharm; 1991 Feb; 10(2):95-109. PubMed ID: 2009737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.
    Skillings JR; Levine M; Rayner HL; Eisenhauer E; Erlichman C; Germond C; Kerr I; Lofters W; Maroun J; Yoshida S
    CMAJ; 1991 Feb; 144(3):297-301. PubMed ID: 1989708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levamisole as a therapeutic agent for colorectal carcinoma.
    Grem JL
    Cancer Cells; 1990 May; 2(5):131-7. PubMed ID: 2201339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant chemotherapy in cancers of the colon and rectum].
    Bleiberg H
    Rev Prat; 1994 Dec; 44(20):2721-6. PubMed ID: 7878362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant systemic chemo- or immunotherapy of colon cancer].
    Schlag PM
    Chirurg; 1994 Jun; 65(6):503-8. PubMed ID: 8088205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of recurrence for advanced colon cancer modified by whole abdominal radiation and chemotherapy.
    Estes NC; Giri S; Fabian C
    Am Surg; 1996 Jul; 62(7):546-49; discussion 549-50. PubMed ID: 8651549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of levamisole (decaris) in patients with inoperable lung cancer].
    Pivniuk VM; Kas'ianenko IV; Pivniuk NA
    Vopr Onkol; 1987; 33(5):82-6. PubMed ID: 3495925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for adjuvant therapy in bowel cancer?
    Marsh JC
    J Clin Gastroenterol; 1994 Apr; 18(3):184-8. PubMed ID: 8034911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant therapy of colon cancer stage C MAC. Adverse effects and efficacy in the Department of Oncology, Soroka Medical Center in the years 1991-1994].
    Ezekiel G; Walfisch S; Cohen Y
    Harefuah; 1999 Jun; 136(12):923-6, 1004, 1003. PubMed ID: 10955148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant therapy in colorectal cancer.
    Hesketh PJ; Bulger KN
    Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy of colon cancer: what should we be doing.
    Harvey VJ
    N Z Med J; 1991 Jul; 104(915):280-1. PubMed ID: 1852327
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progress of adjuvant chemotherapy in colon cancer].
    Toge T
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):554-9. PubMed ID: 8678512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.